SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.18-0.3%Nov 28 12:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Olu Emuleomo who started this subject2/14/2004 4:46:33 PM
From: Robert K.   of 17367
 
How do you spell asthma? Also> Just remember Raptiva does NOT need a phase 3 to see a new use emerge. They merely need to present some nifty data and let the docs do what they will.
Like I said. Gonna be lotsa MLO's running about and Amgen better watch their backs.......
And yes, Serono seems to have a itchy trigger finger with regards to willingness to persue sales.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News